Elan Targets Teva Again Over Generic Focalin XR
Elan Corp. PLC sued Teva Pharmaceuticals USA Inc. on Monday in Delaware over the generics maker's latest efforts to market its own version of attention deficit hyperactivity disorder drug Focalin XR....To view the full article, register now.
Already a subscriber? Click here to view full article